Basis: Current FMP quote-based enterprise value / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The EV/FCF ratio is N/A as of 2026-10-06T20:33:10.741Z.
Calculation as of: 2026-10-06T20:33:10.741Z.
Quote observation: 2026-10-06T20:00:00.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: e70a31ba84f000c4f33ebb31a0a06a86ed13fe2ad2db34235caa158b2a7ba390
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2016-02-24.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
EV/FCF RATIO
N/A
EV/FCF RATIO AVG TTM
N/A
EV/FCF RATIO AVG 3Y
N/A
EV/FCF RATIO AVG 5Y
N/A
EV/FCF RATIO AVG 10Y
N/A
EV/FCF RATIO AVG 15Y
N/A
EV/FCF RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Market Cap
$1.52M
EV/FCF Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | EV/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | $1.81M | N/A | N/A | N/A | N/A |
| Profusa, Inc. Common Stock (PFSA)vs › | $1.83M | N/A | N/A | N/A | N/A |
| Beyond Air, Inc. (XAIR)vs › | $1.84M | N/A | 72.16x | 72.16x | 72.16x |
| Tenon Medical, Inc. (TNON)vs › | $1.84M | N/A | N/A | N/A | N/A |
| TransCode Therapeutics, Inc. (RNAZ)vs › | $1.88M | N/A | N/A | N/A | N/A |
| Autonomix Medical, Inc. (AMIX)vs › | $1.88M | N/A | N/A | N/A | N/A |
| Silo Pharma, Inc. (SILO)vs › | $1.64M | N/A | N/A | N/A | N/A |
| Lakewood-Amedex Biotherapeutics, Inc. (LABT)vs › | $1.52M | N/A | N/A | N/A | N/A |
| GeoVax Labs, Inc. (GOVX)vs › | $2.13M | N/A | N/A | N/A | N/A |
| Vivos Therapeutics, Inc. (VVOS)vs › | $2.14M | N/A | N/A | N/A | N/A |
EV/FCF
N/A
P/FCF
N/A
FCF Yield
N/A
Formula: EV/FCF = Enterprise Value / Free Cash Flow
EV/FCF vs P/FCF:
EV/FCF = Enterprise Value / Free Cash Flow (TTM)
Enterprise value to free cash flow compares total company value to the cash the business generates after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EV/FCF RATIO |
|---|---|
| 2016-02-24 | 62.52x |
| 2016-02-23 | 56.08x |
| 2016-02-22 | 47.77x |
| 2016-02-19 | 45.62x |
| 2016-02-18 | 45.44x |
| 2016-02-17 | 48.24x |
| 2016-02-16 | 45.34x |
| 2016-02-12 | 40.49x |
| 2016-02-11 | 39.55x |
| 2016-02-10 | 38.43x |
| 2016-02-09 | 39.18x |
| 2016-02-08 | 34.23x |
| 2016-02-05 | 35.82x |
| 2016-02-04 | 38.15x |
| 2016-02-03 | 36.01x |
| 2016-02-02 | 35.17x |
| 2016-02-01 | 37.31x |
| 2016-01-29 | 34.61x |
| 2016-01-28 | 33.86x |
| 2016-01-27 | 36.19x |
| 2016-01-26 | 40.67x |
| 2016-01-25 | 40.39x |
| 2016-01-22 | 42.17x |
| 2016-01-21 | 39.46x |
| 2016-01-20 | 41.42x |
| 2016-01-19 | 39.27x |
| 2016-01-15 | 43.66x |
| 2016-01-14 | 44.13x |
| 2016-01-13 | 41.05x |
| 2016-01-12 | 46.74x |
| 2016-01-11 | 47.12x |
| 2016-01-08 | 53.56x |
| 2016-01-07 | 54.58x |
| 2016-01-06 | 56.17x |
| 2016-01-05 | 62.71x |
| 2016-01-04 | 62.61x |
| 2015-12-31 | 65.79x |
| 2015-12-30 | 67.37x |
| 2015-12-29 | 65.97x |
| 2015-12-28 | 63.64x |
| 2015-12-24 | 66.63x |
| 2015-12-23 | 67.00x |
| 2015-12-22 | 64.20x |
| 2015-12-21 | 64.95x |
| 2015-12-18 | 63.55x |
| 2015-12-17 | 65.32x |
| 2015-12-16 | 68.03x |
| 2015-12-15 | 69.43x |
| 2015-12-14 | 67.65x |
| 2015-12-11 | 72.97x |
| 2015-12-10 | 78.30x |
| 2015-12-09 | 81.19x |
| 2015-12-08 | 83.99x |
| 2015-12-07 | 82.12x |
| 2015-12-04 | 94.91x |
| 2015-12-03 | 102.01x |
| 2015-12-02 | 106.67x |
| 2015-12-01 | 107.05x |
| 2015-11-30 | 110.32x |
| 2015-11-27 | 112.28x |
| 2015-11-25 | 108.82x |
| 2015-11-24 | 105.93x |
| 2015-11-23 | 106.30x |
| 2015-11-20 | 104.71x |
| 2015-11-19 | 108.17x |
| 2015-11-18 | 107.80x |
| 2015-11-17 | 106.58x |
| 2015-11-16 | 107.51x |
| 2015-11-13 | 109.01x |
| 2015-11-12 | 110.60x |
| 2015-11-11 | 120.12x |
| 2015-11-10 | 124.23x |
| 2015-11-09 | 118.72x |
| 2015-11-06 | 116.10x |
| 2015-11-05 | 108.64x |
| 2015-11-04 | 112.93x |
| 2015-11-03 | 110.69x |